FEATURED
In a two-part commentary, Dr. Ke-Neng Chen discusses how surgeons must adjust in light of recent clinical trials, beginning with a discussion of the challenges of TNM staging. Read more
LATEST NEWS
Drs. Christian Rolfo and Valeria Denninghoff contend that data show improvements in outcomes from personalized treatment may have stalled and that increased testing for driver gene... Read more
Speaking with Dr. Narjust Florez, Prof. Solomon discusses the design and results of the ALINA trial. Read more
The US approved alectinib as adjuvant treatment based on a significant DFS benefit compared to chemotherapy. Read more